Martijn J H Tjan Selected Research

Ipilimumab

1/2023

Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martijn J H Tjan Research Topics

Disease

2	Neoplasms (Cancer) 01/2023 - 08/2022
1	Duodenitis 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Colitis 01/2023
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 08/2022
1	Acinar Cell Carcinoma 08/2022
1	Mucoepidermoid Carcinoma 08/2022
1	Carcinoma (Carcinomatosis) 08/2022
1	Microsatellite Instability 08/2022
1	Adenoid Cystic Carcinoma (Cylindroma) 08/2022
1	Carcinogenesis 01/2019
1	Constipation 01/2019
1	Inflammation (Inflammations) 01/2019
1	Cerebrotendinous Xanthomatosis 01/2019
1	Gallstones (Gallstone) 01/2019

Drug/Important Bio-Agent (IBA)

1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	tofacitinibIBA 01/2023
1	NivolumabIBA 01/2023
1	IpilimumabIBA 01/2023
1	NucleotidesIBA 08/2022
1	DNA (Deoxyribonucleic Acid)IBA 08/2022
1	RNA (Ribonucleic Acid)IBA 08/2022
1	Bacteroides fragilis toxinIBA 01/2019
1	Bile Acids and Salts (Bile Acids)IBA 01/2019
1	Chenodeoxycholic Acid (Chenix)FDA Link 01/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	fragilysinIBA 01/2019

Therapy/Procedure

2	Therapeutics 01/2023 - 08/2022